Stock Events

Medtronic 

€76.8
4
-€2.42-3.05% Thursday 16:10

Statistics

Day High
77
Day Low
76.8
52W High
84.54
52W Low
67.98
Volume
72
Avg. Volume
76
Mkt Cap
-
P/E Ratio
-
Dividend Yield
3.27%
Dividend
2.51

Upcoming

Dividends

3.27%Dividend Yield
10Y Growth
11.92%
5Y Growth
8.9%
3Y Growth
8.91%
1Y Growth
0.09%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1MDT.MI. It's not an investment recommendation.

About

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Show more...
CEO
Mr. Geoffrey Straub Martha
Employees
95000
Country
IE
ISIN
IE00BTN1Y115
WKN
000A14M2J

Listings